Clinical Trials Browser

Carcinoma, Squamous Cell, Laryngeal Diseases

Cervical Esophagus Adenocarcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Prostatic Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Stomach Neoplasms

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Stomach Neoplasms

Lung Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Salivary Gland Neoplasms

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Breast Neoplasms

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms

Head and Neck Neoplasms

Carcinoma, Squamous Cell

Prostatic Neoplasms

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Breast Neoplasms

Salivary Gland Neoplasms, Thyroid Neoplasms

Breast Neoplasms

Urinary Bladder Neoplasms

Gastroesophageal Adenocarcinoma

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Prostatic Neoplasms

Urinary Bladder Neoplasms

Breast Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms

HER2-positive Early-stage Breast Cancer

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Clinical Trials

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

ADAPT-BLADDER

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

HARMONY

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

IMMUNOLIFE2

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

CABA-DOC

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

ctDNA in HER2+ EBC Neoadjuvant Treatment

MEDINDUCTION

Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)

THUNDER

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

VAROCE

iPRIME

CARABELA

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer

ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

(NeoScorch HN)

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Intravesical Gem/Doce in Patients With NMIBC

Opti-HER2

RACE

TARMAC

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

EUREKA Study:Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer